Singapore gets South-East Asia's first accredited cord blood bank:
This article was originally published in Clinica
Executive Summary
The first umbilical cord blood bank in South-East Asia to receive accreditation from the prestigious, non-profit American Association of Blood Banks (AABB) is CordLife, based in Singapore. CordLife is a subsidiary of Australian cell therapy company CyGenics. It is now one of just 35 private and public cord blood banks around the world to have achieved the accreditation from the AABB and the eighth outside the US. The accreditation process, which is a time-consuming and expensive exercise, extends also into non-lab functions such as sales, marketing and HR. It is a globally recognised standard for all operating cord blood banks.